Zydus Wellness enters the Q1 FY27 results facing the dual challenge of integrating its international Comfort Click operations while managing a seasonal peak for domestic brands like Nycil and Glucon-D. Investors will be focused on whether the company can sustain its 17–18% EBITDA margin target amidst rising edible oil costs and a leadership transition in its sales division.
| Results date | August 04, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 1,476.1 Cr |
| Previous quarter PAT | Rs. 162.0 Cr |
| Previous quarter EBITDA margin | 18.2% |
| Market cap | Rs. 18007.9 Cr |
| CMP | Rs. 566.0 |
The board will consider the Q1 FY27 unaudited financial results on August 04, 2026.
The company recommended a final dividend of Rs. 1.20 per share for FY26, with a record date of July 17, 2026, and payment scheduled on or after August 07, 2026.
Management's path to a 17–18% EBITDA margin remains the primary focus for Q1 FY27, testing whether the company can maintain profitability despite the edible oil tariff value hike to USD 1,218/tonne effective June 1, 2026. The seasonal performance of Nycil and Glucon-D is critical this quarter, given the low base of an 18.8% decline in FY26 and the potential impact of above-normal temperatures. While the consolidated base benefits from the Comfort Click digital VMS subsidiary—which management guided to 14%+ EBITDA margins—the core business faces pressure from rising input costs and the ongoing sales leadership transition following the resignation of the Head of Sales effective July 3, 2026. The upcoming call will likely address the impact of rupee depreciation on the EUR-denominated acquisition debt, which stood at Rs. 30,349 Mn at the end of FY26.
EBITDA margin and cost management: Tracking progress toward the 17–18% margin target amidst inflationary headwinds.
Seasonal and segment performance: Monitoring the recovery of core brands and the contribution of the digital VMS business.
Strategic and leadership transitions: Addressing organizational changes and reporting transparency.
Seasonal brands, including Nycil and Glucon-D, saw a revenue decline of 18.8% in FY26. This performance was largely attributed to unseasonal and extended monsoons which impacted demand.
Comfort Click became cash EPS accretive post-interest and tax in Q3 FY26 and is guided to maintain EBITDA margins of 14% or higher. Integration is ongoing, with seven new product launches in Q4 FY26 and the recent incorporation of international subsidiaries in Dubai and Ireland.
The Comfort Click acquisition was initially funded via a bridge loan at approximately 5% interest, which was subsequently refinanced into a EUR loan. As of the end of FY26, the company held Rs. 30,349 Mn in non-current borrowings.
The company has set a target of 17–18% EBITDA margin to be achieved over the two years following Q2 FY26. While the exit margin in Q4 FY26 was 18.2%, the full-year FY26 margin was 12.9%, indicating that the target timeline extends into FY27–FY28.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now